Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Alfacalcidol). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
Indications & Uses
Viva-D soft is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Initial dosing for adults starts at 0.25 mcg per day for the first 2 months, unless hypercalcemia develops. If hypercalcemia occurs, the dose should be cut back to 0.25 mcg every other day. If serum calcium stays below the desired range, the dose may instead be increased in steps of 0.25 mcg/day every 2 months. Maintenance doses: most patients are maintained on 0.5 mcg/day, though doses as high as 1 mcg/day may be needed to keep serum calcium within the desired range. Serum calcium and phosphate levels should be checked monthly, or more often if hypercalcemia develops. If hypercalcemia develops at any point during treatment, the alfacalcidol dose should be cut by 50%, and all calcium supplements should be stopped until calcium levels return to normal. Pediatrics: the safety and efficacy of alfacalcidol in children have not been established.
Side Effects
Elevated blood urea nitrogen (BUN), albuminuria, hypercholesterolemia, elevated aspartate aminotransferase (AST or SGOT) and alanine aminotransferase (ALT or SGPT), anorexia, weight loss, polydipsia, hyperthermia, dry mouth, metallic taste Cardiac arrhythmia, hypertension Conjunctivitis, corneal calcification, photophobia Rhinorrhea Overt psychosis Headache, somnolence, vertigo Diarrhoea, vomiting, constipation, nausea, pancreatitis Pruritus Muscle pain, bone pain, ectopic calcification Polyuria, nocturia Decreased libido Fatigue, weakness
Cautions & Contraindications
Warnings & Precautions
Pregnancy, lactation, renal impairment, infants, elderly. Monitor serum levels of calcium in patients with renal failure. Caution in hypercalciuria in those with history of renal calculi. Avoid in patients with hypersensitivity to inj. containing propylene glycol.
Contraindications
Alfacalcidol should not be used by anyone who is hypersensitive to the drug, to any ingredient in its formulation (including non-medicinal ingredients), or to any part of the container; the full listing of these can be found under Dosage Forms, Strengths, Composition and Packaging. It is also contraindicated when blood tests show hypercalcemia, hyperphosphatemia, or other evidence of vitamin D overdose.